Apical effect of diosmectite on damage to the intestinal barrier induced by basal tumour necrosis factor-α

Gut

Volumn 40, Issue 3, 1997, Pages 339-343

  Mahraoui, L ^a   Heyman, M ^a   Plique, O ^b   Droy Lefaix, M T ^b   Desjeux, J F ^a  

^a Hopital Saint Lazare   (France)

^b IPSEN   (France)

Author keywords

diosmectite; HT29 19A cell line; intestinal permeability; TNF ; Ussing chambers

Indexed keywords

DIOSMECTITE; GAMMA INTERFERON; GASTROINTESTINAL AGENT; HORSERADISH PEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL DAMAGE; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE; PRIORITY JOURNAL;

EID: 0030987118     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.40.3.339     Document Type: Article

References (47)

1. Powell DW. New paradigms for the pathophysiology of infectious diarrhea [editorial; comment], Gastroenterology 1994; 106: 1705-7.
2. Crowe SE, Powell DW. Fluid and electrolyte transport during enteric infections. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995; 8: 107-41.
3. Mathan MM, Chandy G, Mathan VI. Ultrastructural changes in the upper small intestinal mucosa in patients with cholera. Gastroenterology 1995; 109: 422-30.
4. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzycka-Wroblewska E, et al. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95: 55-65.
5. Brennan FM, Maini RN, Feldmann M. Cytokine expression in chronic inflammatory disease. Br Med Bull 1995; 51: 368-84.
6. Heyman M, Darmon N, Dupont C, Dugas B, Hirribaren A, Blaton MA, et al. Mononuclear cells from infants allergic to cow's milk secrete tumor necrosis factor alpha, altering intestinal function. Gastroenterology 1994; 106: 1514-23.
7. Heyman M, Desjeux JF. Significance of intestinal food protein transport. J Pediatr Gastroenterol Nutr 1992; 15: 48-57.
8. Adams RB, Planchon SM, Roche JK. IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding. J Immunol 1993; 150: 2356-63.
9. Castro GA, Powell DW. The physiology of the mucosal immune system and immune-mediated responses in the gastrointestinal tract. In: Johnson LR, Alpers DA, Christensen J, Jacobson ED, Walsh JH, eds. Physiology of the gastrointestinal tract. 3rd edn. New York: Raven Press, 1994; 17: 709-50.
10. Goldblum S, Ding X, Campbell-Washington J. TNF-α induces endothelial cell F-actin depolymerization, new actin synthesis, and barrier dysfunction. Am J Physiol 1993; 264: C894-905.
11. Remick DG, Kunkel SL. Pathophysiologic alterations induced by tumor necrosis factor. Int Rev Exp Pathol 1993; 34: 7-25.
12. Singh G, Chaudry KI, Morrison MH, Chaudry IH. Tumor necrosis factor depresses gut absorptive function. Circulation and Shock 1993; 39: 279-84.
13. Garside P, Bunce C, Tomlinson RC, Nichols BL, Mowat AM. Analysis of enteropathy induced by tumour necrosis factor alpha. Cytokine 1993; 5: 24-30.
14. Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggitt D. Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 1987; 128: 410-25.
15. Taverne J, Rayner DC, Van der Meide PH, Lydyard PM, Bidey SP, Cooke A. Cytotoxicity of tumor necrosis factor for thyroid epithelial cells and its regulation by interferongamma. Eur J Immunol 1987; 17: 1855-8.
16. Weetman AP, Rees AJ. Synergistic effects of recombinant tumour necrosis factor and interferon-gamma on rat thyroid cell growth and la antigen expression. Immunology 1988; 63: 285-9.
17. Schiller JH, Bittner G, Storer B, Willson JKV. Synergistic antitumor effects of tumor necrosis factor and gammainterferon on human colon carcinoma cells. Cancer Res 1987; 47: 2809-13.
18. Ruggiero V, Tavernier J, Fiers W, Baglioni C. Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol 1986; 136: 2445-50.
19. Tsujimoto M, Yip YK, Vilocek J. Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor. J Immunol 1986; 136: 2441-4.
20. van Dullemen HM, van Deventer SJ, Hommes DW, Bijl HA, Jansen J, Tytgat GN, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995; 109: 129-35.
21. Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G, et al. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet 1993; 342: 173-4.
22. Fioramonti J. Antidiarrheal properties of clay minerals: pharmacological and clinical studies. In: Simon F, Lees P, Semjen G, eds. Veterinary pharmacology toxicology and therapy in food producing animals. Budapest: Unipharma, 1990: 245-51.
23. Madkour AA, Madina EM, el-Azzouni OE, Amer MA, el-Walili TM, Abbass T. Smectite in acute diarrhea in children: a double-blind placebo-controlled clinical trial. J Pediatr Gastroenterol Nutr 1993; 17: 176-81.
24. Vivatvakin B, Jongpipatvanich S, Harikul S, Eksaengri P, Lortholary O. Control study of oral rehydration solution (ORS)/ORS + dioctahedral smectite in hospitalized Thai infants with acute secretory diarrhea. Southeast Asian J Trop Med Public Health 1992; 23: 414-9.
25. Lexomboon U, Harikul S, Lortholary O. Control randomized study of rehydration/rehydration with dioctahedral smectite in ambulatory Thai infants with acute diarrhea. Southeast Asian J Trop Med Public Health 1994; 25: 157-62.
26. Leber W. A new suspension form of smectite (Liquid 'Diasorb') for the treatment of acute diarrhoea: a randomized comparative study. Pharmatherapeutica 1988; 5: 256-60.
27. Fioramonti J, Fargeas MJ, Bueno L, Droy-Lefaix MT. Action of T-2 toxin on gastrointestinal transit in mice: protective effect of an argillaceous compound. Toxicol Lett 1987; 36: 227-32.
28. Kheroua O, Jutteau J, Tome D, Desjeux JF. Action de la smectite en présence de la toxine cholérique et de la solution de réhydratation sur les mouvements d'eau et d'électrolytes dans l'intestin du rat. Gastroenterol Clin Biol 1987; 11: 240A.
29. Navetat H, Droy MT, Espinasse J. Infection expérimentale du veau par le colibacille K99+: Effet protecteur de la smectite. Bulletin de l'Académie Vétérinaire de France 1988; 61: 365-75.
30. Rey C. Diarrhées virales à rotavirus. Intérêt de la Smectite. Revue Internationale de Pediatrics 1989; 196: 33-7.
31. Rateau JG, Morgant G, Droy-Priot MT, Parier JL. A histological, enzymatic and water-electrolyte study of the action of smectite, a mucoprotective clay, on experimental infectious diarrhoea in the rabbit. Curr Med Res Opin 1982; 8: 233-41.
32. Rateau J, Parier J. Etude de la sécrétion du mucus gastrique du rat après ingestion de topique. Ann Gastroenterol Hepatol (Paris) 1979; 15: 1-7.
33. Dupont C, Moreno JL, Barau E, Bargaoui K, Thiane E, Plique O. Effect of diosmectite on intestinal permeability changes in acute diarrhea: a double-blind placebocontrolled trial. J Pediatr Gastroenterol Nutr 1992; 14: 413-9.
34. Vermeulen L, Droy-Lefaix M, Rampal P. In vitro study of the effects of dioctahedric smectite on the induction of cyclic AMP by cholerotoxin. In: Proceedings of IX World Congresses of Gastroenterology. Sydney: 1990.
35. Fioramonti J, Droy-Lefaix MT, Bueno L. Changes in gastro-intestinal motility induced by cholera toxin and experimental osmotic diarrhoea in dogs: effects of treatment with an argillaceous compound. Digestion 1987; 36: 230-7.
36. Leonard A, Droy-Lefaix MT, Allen A, Plachon SM. Pepsin hydrolysis of the adherent mucus barrier and subsequent gastric mucosal damage in the rat: effect of diosmectite and 16, 16 dimethyl prostaglandin E2. Gastroenterol Clin Biol 1994; 18: 609-16.
37. Theodorou V, Fioramonti J, Droy-Lefaix MT, Plique O, Bueno L. Protective action of diosmectite treatment on digestive disturbances induced by intestinal anaphylaxis in the guinea-pig. Aliment Pharmacol Ther 1994; 8: 295-9.
38. Augeron C, Laboisse CL. Emergence of permanently differentiated cell clones in a human colonic cancer cell line in culture after treatment with sodium butyrate. Cancer Res 1984; 44: 3961-9.
39. Maehly AC, Chance B. The assay of catalases and peroxidases. In: Glick D, ed. Methods of biochemical analysis (vol 1). New York: Wiley Intersciences, 1954: 357-98.
40. SAS user's guide: basics. 5th ed. Cary, NC: SAS, 1985.
41. Rodriguez P, Heyman M, Candalh C, Blaton MA, Bouchaud C. Tumour necrosis factor-alpha induces morphological and functional alterations of intestinal HT29 cl.19A cell monolayers. Cytokine 1995; 7: 441-8.
42. Desjeux JF, Boisset M. Assessment of bioavailability through the gastro-intestinal tract. In: Couvreur P, Duchêne D, Kalles I, eds. Formulation of poorly-available drugs for oral administration. Paris: Editions de Santé, 1996: 33-49.
43. Heyman M, Ducroc R, Desjeux JF, Morgat JL. Horseradish peroxidase transport across adult rabbit jejunum in vitro. Am J Physiol 1982; 242: G558-64.
44. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, et al. 5′-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J Clin Invest 1993; 91: 2320-5.
45. Resnick MB, Colgan SP, Patapoff TW, Mrsny RJ, Awtrey CS, Delp-Archer C, et al. Activated eosinophils evoke chloride secretion in model intestinal epithelia primarily via regulated release of 5'-AMP. J Immunol 1993; 151: 5716-23.
46. Grim R. Clay mineralogy. New York: McGraw Hill, 1968.
47. Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature 1995; 377: 435-8.